Global Meningococcal Disease Vaccine Supply, Demand and Key Producers, 2023-2029
The global Meningococcal Disease Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Meningococcal disease vaccination is a biological material given to prevent meningitis, a contagious disease of the membranes surrounding the spinal cord and brain. Conjugate, polysaccharide, and subcapsular meningococcal vaccines are the three main types of meningococcal vaccinations. They target meningococcal bacteria A, B, C, W-135, and Y and are given to new-borns, children, and adults to immunize them against the invasive disease. Antibodies are generated after the vaccination is given to combat the bacteria and develop an immune response to prevent infection.
This report studies the global Meningococcal Disease Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Meningococcal Disease Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meningococcal Disease Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Meningococcal Disease Vaccine total production and demand, 2018-2029, (K Units)
Global Meningococcal Disease Vaccine total production value, 2018-2029, (USD Million)
Global Meningococcal Disease Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Meningococcal Disease Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Meningococcal Disease Vaccine domestic production, consumption, key domestic manufacturers and share
Global Meningococcal Disease Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Meningococcal Disease Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Meningococcal Disease Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Meningococcal Disease Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Johnson & Johnson, Mylan N.V, Teva Pharmaceutical Industries Ltd, Pfizer Inc, GlaxoSmithKline plc, Novartis AG, Sanofi and Merck & Co., Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meningococcal Disease Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Meningococcal Disease Vaccine Market, By Region:
1. How big is the global Meningococcal Disease Vaccine market?
2. What is the demand of the global Meningococcal Disease Vaccine market?
3. What is the year over year growth of the global Meningococcal Disease Vaccine market?
4. What is the production and production value of the global Meningococcal Disease Vaccine market?
5. Who are the key producers in the global Meningococcal Disease Vaccine market?
6. What are the growth factors driving the market demand?
Meningococcal disease vaccination is a biological material given to prevent meningitis, a contagious disease of the membranes surrounding the spinal cord and brain. Conjugate, polysaccharide, and subcapsular meningococcal vaccines are the three main types of meningococcal vaccinations. They target meningococcal bacteria A, B, C, W-135, and Y and are given to new-borns, children, and adults to immunize them against the invasive disease. Antibodies are generated after the vaccination is given to combat the bacteria and develop an immune response to prevent infection.
This report studies the global Meningococcal Disease Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Meningococcal Disease Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meningococcal Disease Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Meningococcal Disease Vaccine total production and demand, 2018-2029, (K Units)
Global Meningococcal Disease Vaccine total production value, 2018-2029, (USD Million)
Global Meningococcal Disease Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Meningococcal Disease Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Meningococcal Disease Vaccine domestic production, consumption, key domestic manufacturers and share
Global Meningococcal Disease Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Meningococcal Disease Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Meningococcal Disease Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Meningococcal Disease Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Johnson & Johnson, Mylan N.V, Teva Pharmaceutical Industries Ltd, Pfizer Inc, GlaxoSmithKline plc, Novartis AG, Sanofi and Merck & Co., Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meningococcal Disease Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Meningococcal Disease Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Polysaccharide
- Conjugate
- Combination
- Infant
- Child
- Aldult
- AstraZeneca
- Johnson & Johnson
- Mylan N.V
- Teva Pharmaceutical Industries Ltd
- Pfizer Inc
- GlaxoSmithKline plc
- Novartis AG
- Sanofi
- Merck & Co., Inc.
- F. Hoffmann-La Roche Ltd
- Baxter
- BIO-MED
- Bio-Manguinhos
- Walvax Biotechnology Co., Ltd
1. How big is the global Meningococcal Disease Vaccine market?
2. What is the demand of the global Meningococcal Disease Vaccine market?
3. What is the year over year growth of the global Meningococcal Disease Vaccine market?
4. What is the production and production value of the global Meningococcal Disease Vaccine market?
5. Who are the key producers in the global Meningococcal Disease Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Meningococcal Disease Vaccine Introduction
1.2 World Meningococcal Disease Vaccine Supply & Forecast
1.2.1 World Meningococcal Disease Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Meningococcal Disease Vaccine Production (2018-2029)
1.2.3 World Meningococcal Disease Vaccine Pricing Trends (2018-2029)
1.3 World Meningococcal Disease Vaccine Production by Region (Based on Production Site)
1.3.1 World Meningococcal Disease Vaccine Production Value by Region (2018-2029)
1.3.2 World Meningococcal Disease Vaccine Production by Region (2018-2029)
1.3.3 World Meningococcal Disease Vaccine Average Price by Region (2018-2029)
1.3.4 North America Meningococcal Disease Vaccine Production (2018-2029)
1.3.5 Europe Meningococcal Disease Vaccine Production (2018-2029)
1.3.6 China Meningococcal Disease Vaccine Production (2018-2029)
1.3.7 Japan Meningococcal Disease Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Meningococcal Disease Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Meningococcal Disease Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Meningococcal Disease Vaccine Demand (2018-2029)
2.2 World Meningococcal Disease Vaccine Consumption by Region
2.2.1 World Meningococcal Disease Vaccine Consumption by Region (2018-2023)
2.2.2 World Meningococcal Disease Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Meningococcal Disease Vaccine Consumption (2018-2029)
2.4 China Meningococcal Disease Vaccine Consumption (2018-2029)
2.5 Europe Meningococcal Disease Vaccine Consumption (2018-2029)
2.6 Japan Meningococcal Disease Vaccine Consumption (2018-2029)
2.7 South Korea Meningococcal Disease Vaccine Consumption (2018-2029)
2.8 ASEAN Meningococcal Disease Vaccine Consumption (2018-2029)
2.9 India Meningococcal Disease Vaccine Consumption (2018-2029)
3 WORLD MENINGOCOCCAL DISEASE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Meningococcal Disease Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Meningococcal Disease Vaccine Production by Manufacturer (2018-2023)
3.3 World Meningococcal Disease Vaccine Average Price by Manufacturer (2018-2023)
3.4 Meningococcal Disease Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Meningococcal Disease Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Meningococcal Disease Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Meningococcal Disease Vaccine in 2022
3.6 Meningococcal Disease Vaccine Market: Overall Company Footprint Analysis
3.6.1 Meningococcal Disease Vaccine Market: Region Footprint
3.6.2 Meningococcal Disease Vaccine Market: Company Product Type Footprint
3.6.3 Meningococcal Disease Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Meningococcal Disease Vaccine Production Value Comparison
4.1.1 United States VS China: Meningococcal Disease Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Meningococcal Disease Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Meningococcal Disease Vaccine Production Comparison
4.2.1 United States VS China: Meningococcal Disease Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Meningococcal Disease Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Meningococcal Disease Vaccine Consumption Comparison
4.3.1 United States VS China: Meningococcal Disease Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Meningococcal Disease Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Meningococcal Disease Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Meningococcal Disease Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023)
4.5 China Based Meningococcal Disease Vaccine Manufacturers and Market Share
4.5.1 China Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Meningococcal Disease Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023)
4.6 Rest of World Based Meningococcal Disease Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Meningococcal Disease Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Polysaccharide
5.2.2 Conjugate
5.2.3 Combination
5.3 Market Segment by Type
5.3.1 World Meningococcal Disease Vaccine Production by Type (2018-2029)
5.3.2 World Meningococcal Disease Vaccine Production Value by Type (2018-2029)
5.3.3 World Meningococcal Disease Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Meningococcal Disease Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Infant
6.2.2 Child
6.2.3 Aldult
6.3 Market Segment by Application
6.3.1 World Meningococcal Disease Vaccine Production by Application (2018-2029)
6.3.2 World Meningococcal Disease Vaccine Production Value by Application (2018-2029)
6.3.3 World Meningococcal Disease Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AstraZeneca
7.1.1 AstraZeneca Details
7.1.2 AstraZeneca Major Business
7.1.3 AstraZeneca Meningococcal Disease Vaccine Product and Services
7.1.4 AstraZeneca Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AstraZeneca Recent Developments/Updates
7.1.6 AstraZeneca Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Meningococcal Disease Vaccine Product and Services
7.2.4 Johnson & Johnson Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Mylan N.V
7.3.1 Mylan N.V Details
7.3.2 Mylan N.V Major Business
7.3.3 Mylan N.V Meningococcal Disease Vaccine Product and Services
7.3.4 Mylan N.V Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mylan N.V Recent Developments/Updates
7.3.6 Mylan N.V Competitive Strengths & Weaknesses
7.4 Teva Pharmaceutical Industries Ltd
7.4.1 Teva Pharmaceutical Industries Ltd Details
7.4.2 Teva Pharmaceutical Industries Ltd Major Business
7.4.3 Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Product and Services
7.4.4 Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.4.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.5 Pfizer Inc
7.5.1 Pfizer Inc Details
7.5.2 Pfizer Inc Major Business
7.5.3 Pfizer Inc Meningococcal Disease Vaccine Product and Services
7.5.4 Pfizer Inc Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Inc Recent Developments/Updates
7.5.6 Pfizer Inc Competitive Strengths & Weaknesses
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Details
7.6.2 GlaxoSmithKline plc Major Business
7.6.3 GlaxoSmithKline plc Meningococcal Disease Vaccine Product and Services
7.6.4 GlaxoSmithKline plc Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GlaxoSmithKline plc Recent Developments/Updates
7.6.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG Meningococcal Disease Vaccine Product and Services
7.7.4 Novartis AG Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 Sanofi
7.8.1 Sanofi Details
7.8.2 Sanofi Major Business
7.8.3 Sanofi Meningococcal Disease Vaccine Product and Services
7.8.4 Sanofi Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sanofi Recent Developments/Updates
7.8.6 Sanofi Competitive Strengths & Weaknesses
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Details
7.9.2 Merck & Co., Inc. Major Business
7.9.3 Merck & Co., Inc. Meningococcal Disease Vaccine Product and Services
7.9.4 Merck & Co., Inc. Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck & Co., Inc. Recent Developments/Updates
7.9.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.10 F. Hoffmann-La Roche Ltd
7.10.1 F. Hoffmann-La Roche Ltd Details
7.10.2 F. Hoffmann-La Roche Ltd Major Business
7.10.3 F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Product and Services
7.10.4 F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.10.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.11 Baxter
7.11.1 Baxter Details
7.11.2 Baxter Major Business
7.11.3 Baxter Meningococcal Disease Vaccine Product and Services
7.11.4 Baxter Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Baxter Recent Developments/Updates
7.11.6 Baxter Competitive Strengths & Weaknesses
7.12 BIO-MED
7.12.1 BIO-MED Details
7.12.2 BIO-MED Major Business
7.12.3 BIO-MED Meningococcal Disease Vaccine Product and Services
7.12.4 BIO-MED Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 BIO-MED Recent Developments/Updates
7.12.6 BIO-MED Competitive Strengths & Weaknesses
7.13 Bio-Manguinhos
7.13.1 Bio-Manguinhos Details
7.13.2 Bio-Manguinhos Major Business
7.13.3 Bio-Manguinhos Meningococcal Disease Vaccine Product and Services
7.13.4 Bio-Manguinhos Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Bio-Manguinhos Recent Developments/Updates
7.13.6 Bio-Manguinhos Competitive Strengths & Weaknesses
7.14 Walvax Biotechnology Co., Ltd
7.14.1 Walvax Biotechnology Co., Ltd Details
7.14.2 Walvax Biotechnology Co., Ltd Major Business
7.14.3 Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Product and Services
7.14.4 Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Walvax Biotechnology Co., Ltd Recent Developments/Updates
7.14.6 Walvax Biotechnology Co., Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Meningococcal Disease Vaccine Industry Chain
8.2 Meningococcal Disease Vaccine Upstream Analysis
8.2.1 Meningococcal Disease Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Meningococcal Disease Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Meningococcal Disease Vaccine Production Mode
8.6 Meningococcal Disease Vaccine Procurement Model
8.7 Meningococcal Disease Vaccine Industry Sales Model and Sales Channels
8.7.1 Meningococcal Disease Vaccine Sales Model
8.7.2 Meningococcal Disease Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Meningococcal Disease Vaccine Introduction
1.2 World Meningococcal Disease Vaccine Supply & Forecast
1.2.1 World Meningococcal Disease Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Meningococcal Disease Vaccine Production (2018-2029)
1.2.3 World Meningococcal Disease Vaccine Pricing Trends (2018-2029)
1.3 World Meningococcal Disease Vaccine Production by Region (Based on Production Site)
1.3.1 World Meningococcal Disease Vaccine Production Value by Region (2018-2029)
1.3.2 World Meningococcal Disease Vaccine Production by Region (2018-2029)
1.3.3 World Meningococcal Disease Vaccine Average Price by Region (2018-2029)
1.3.4 North America Meningococcal Disease Vaccine Production (2018-2029)
1.3.5 Europe Meningococcal Disease Vaccine Production (2018-2029)
1.3.6 China Meningococcal Disease Vaccine Production (2018-2029)
1.3.7 Japan Meningococcal Disease Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Meningococcal Disease Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Meningococcal Disease Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Meningococcal Disease Vaccine Demand (2018-2029)
2.2 World Meningococcal Disease Vaccine Consumption by Region
2.2.1 World Meningococcal Disease Vaccine Consumption by Region (2018-2023)
2.2.2 World Meningococcal Disease Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Meningococcal Disease Vaccine Consumption (2018-2029)
2.4 China Meningococcal Disease Vaccine Consumption (2018-2029)
2.5 Europe Meningococcal Disease Vaccine Consumption (2018-2029)
2.6 Japan Meningococcal Disease Vaccine Consumption (2018-2029)
2.7 South Korea Meningococcal Disease Vaccine Consumption (2018-2029)
2.8 ASEAN Meningococcal Disease Vaccine Consumption (2018-2029)
2.9 India Meningococcal Disease Vaccine Consumption (2018-2029)
3 WORLD MENINGOCOCCAL DISEASE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Meningococcal Disease Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Meningococcal Disease Vaccine Production by Manufacturer (2018-2023)
3.3 World Meningococcal Disease Vaccine Average Price by Manufacturer (2018-2023)
3.4 Meningococcal Disease Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Meningococcal Disease Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Meningococcal Disease Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Meningococcal Disease Vaccine in 2022
3.6 Meningococcal Disease Vaccine Market: Overall Company Footprint Analysis
3.6.1 Meningococcal Disease Vaccine Market: Region Footprint
3.6.2 Meningococcal Disease Vaccine Market: Company Product Type Footprint
3.6.3 Meningococcal Disease Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Meningococcal Disease Vaccine Production Value Comparison
4.1.1 United States VS China: Meningococcal Disease Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Meningococcal Disease Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Meningococcal Disease Vaccine Production Comparison
4.2.1 United States VS China: Meningococcal Disease Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Meningococcal Disease Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Meningococcal Disease Vaccine Consumption Comparison
4.3.1 United States VS China: Meningococcal Disease Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Meningococcal Disease Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Meningococcal Disease Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Meningococcal Disease Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023)
4.5 China Based Meningococcal Disease Vaccine Manufacturers and Market Share
4.5.1 China Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Meningococcal Disease Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023)
4.6 Rest of World Based Meningococcal Disease Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Meningococcal Disease Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Polysaccharide
5.2.2 Conjugate
5.2.3 Combination
5.3 Market Segment by Type
5.3.1 World Meningococcal Disease Vaccine Production by Type (2018-2029)
5.3.2 World Meningococcal Disease Vaccine Production Value by Type (2018-2029)
5.3.3 World Meningococcal Disease Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Meningococcal Disease Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Infant
6.2.2 Child
6.2.3 Aldult
6.3 Market Segment by Application
6.3.1 World Meningococcal Disease Vaccine Production by Application (2018-2029)
6.3.2 World Meningococcal Disease Vaccine Production Value by Application (2018-2029)
6.3.3 World Meningococcal Disease Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AstraZeneca
7.1.1 AstraZeneca Details
7.1.2 AstraZeneca Major Business
7.1.3 AstraZeneca Meningococcal Disease Vaccine Product and Services
7.1.4 AstraZeneca Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AstraZeneca Recent Developments/Updates
7.1.6 AstraZeneca Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Meningococcal Disease Vaccine Product and Services
7.2.4 Johnson & Johnson Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Mylan N.V
7.3.1 Mylan N.V Details
7.3.2 Mylan N.V Major Business
7.3.3 Mylan N.V Meningococcal Disease Vaccine Product and Services
7.3.4 Mylan N.V Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mylan N.V Recent Developments/Updates
7.3.6 Mylan N.V Competitive Strengths & Weaknesses
7.4 Teva Pharmaceutical Industries Ltd
7.4.1 Teva Pharmaceutical Industries Ltd Details
7.4.2 Teva Pharmaceutical Industries Ltd Major Business
7.4.3 Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Product and Services
7.4.4 Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.4.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.5 Pfizer Inc
7.5.1 Pfizer Inc Details
7.5.2 Pfizer Inc Major Business
7.5.3 Pfizer Inc Meningococcal Disease Vaccine Product and Services
7.5.4 Pfizer Inc Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Inc Recent Developments/Updates
7.5.6 Pfizer Inc Competitive Strengths & Weaknesses
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Details
7.6.2 GlaxoSmithKline plc Major Business
7.6.3 GlaxoSmithKline plc Meningococcal Disease Vaccine Product and Services
7.6.4 GlaxoSmithKline plc Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GlaxoSmithKline plc Recent Developments/Updates
7.6.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG Meningococcal Disease Vaccine Product and Services
7.7.4 Novartis AG Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 Sanofi
7.8.1 Sanofi Details
7.8.2 Sanofi Major Business
7.8.3 Sanofi Meningococcal Disease Vaccine Product and Services
7.8.4 Sanofi Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sanofi Recent Developments/Updates
7.8.6 Sanofi Competitive Strengths & Weaknesses
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Details
7.9.2 Merck & Co., Inc. Major Business
7.9.3 Merck & Co., Inc. Meningococcal Disease Vaccine Product and Services
7.9.4 Merck & Co., Inc. Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck & Co., Inc. Recent Developments/Updates
7.9.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.10 F. Hoffmann-La Roche Ltd
7.10.1 F. Hoffmann-La Roche Ltd Details
7.10.2 F. Hoffmann-La Roche Ltd Major Business
7.10.3 F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Product and Services
7.10.4 F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.10.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.11 Baxter
7.11.1 Baxter Details
7.11.2 Baxter Major Business
7.11.3 Baxter Meningococcal Disease Vaccine Product and Services
7.11.4 Baxter Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Baxter Recent Developments/Updates
7.11.6 Baxter Competitive Strengths & Weaknesses
7.12 BIO-MED
7.12.1 BIO-MED Details
7.12.2 BIO-MED Major Business
7.12.3 BIO-MED Meningococcal Disease Vaccine Product and Services
7.12.4 BIO-MED Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 BIO-MED Recent Developments/Updates
7.12.6 BIO-MED Competitive Strengths & Weaknesses
7.13 Bio-Manguinhos
7.13.1 Bio-Manguinhos Details
7.13.2 Bio-Manguinhos Major Business
7.13.3 Bio-Manguinhos Meningococcal Disease Vaccine Product and Services
7.13.4 Bio-Manguinhos Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Bio-Manguinhos Recent Developments/Updates
7.13.6 Bio-Manguinhos Competitive Strengths & Weaknesses
7.14 Walvax Biotechnology Co., Ltd
7.14.1 Walvax Biotechnology Co., Ltd Details
7.14.2 Walvax Biotechnology Co., Ltd Major Business
7.14.3 Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Product and Services
7.14.4 Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Walvax Biotechnology Co., Ltd Recent Developments/Updates
7.14.6 Walvax Biotechnology Co., Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Meningococcal Disease Vaccine Industry Chain
8.2 Meningococcal Disease Vaccine Upstream Analysis
8.2.1 Meningococcal Disease Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Meningococcal Disease Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Meningococcal Disease Vaccine Production Mode
8.6 Meningococcal Disease Vaccine Procurement Model
8.7 Meningococcal Disease Vaccine Industry Sales Model and Sales Channels
8.7.1 Meningococcal Disease Vaccine Sales Model
8.7.2 Meningococcal Disease Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Meningococcal Disease Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Meningococcal Disease Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Meningococcal Disease Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Meningococcal Disease Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Meningococcal Disease Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Meningococcal Disease Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Meningococcal Disease Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Meningococcal Disease Vaccine Production Market Share by Region (2018-2023)
Table 9. World Meningococcal Disease Vaccine Production Market Share by Region (2024-2029)
Table 10. World Meningococcal Disease Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Meningococcal Disease Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Meningococcal Disease Vaccine Major Market Trends
Table 13. World Meningococcal Disease Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Meningococcal Disease Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Meningococcal Disease Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Meningococcal Disease Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Meningococcal Disease Vaccine Producers in 2022
Table 18. World Meningococcal Disease Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Meningococcal Disease Vaccine Producers in 2022
Table 20. World Meningococcal Disease Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Meningococcal Disease Vaccine Company Evaluation Quadrant
Table 22. World Meningococcal Disease Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Meningococcal Disease Vaccine Production Site of Key Manufacturer
Table 24. Meningococcal Disease Vaccine Market: Company Product Type Footprint
Table 25. Meningococcal Disease Vaccine Market: Company Product Application Footprint
Table 26. Meningococcal Disease Vaccine Competitive Factors
Table 27. Meningococcal Disease Vaccine New Entrant and Capacity Expansion Plans
Table 28. Meningococcal Disease Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Meningococcal Disease Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Meningococcal Disease Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Meningococcal Disease Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Meningococcal Disease Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Meningococcal Disease Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Meningococcal Disease Vaccine Production Market Share (2018-2023)
Table 37. China Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Meningococcal Disease Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Meningococcal Disease Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Meningococcal Disease Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Market Share (2018-2023)
Table 47. World Meningococcal Disease Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Meningococcal Disease Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Meningococcal Disease Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Meningococcal Disease Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Meningococcal Disease Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Meningococcal Disease Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Meningococcal Disease Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Meningococcal Disease Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Meningococcal Disease Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Meningococcal Disease Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Meningococcal Disease Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Meningococcal Disease Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Meningococcal Disease Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Meningococcal Disease Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Major Business
Table 63. AstraZeneca Meningococcal Disease Vaccine Product and Services
Table 64. AstraZeneca Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AstraZeneca Recent Developments/Updates
Table 66. AstraZeneca Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Meningococcal Disease Vaccine Product and Services
Table 70. Johnson & Johnson Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
Table 73. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 74. Mylan N.V Major Business
Table 75. Mylan N.V Meningococcal Disease Vaccine Product and Services
Table 76. Mylan N.V Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mylan N.V Recent Developments/Updates
Table 78. Mylan N.V Competitive Strengths & Weaknesses
Table 79. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Teva Pharmaceutical Industries Ltd Major Business
Table 81. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Product and Services
Table 82. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 84. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 85. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Inc Major Business
Table 87. Pfizer Inc Meningococcal Disease Vaccine Product and Services
Table 88. Pfizer Inc Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Pfizer Inc Competitive Strengths & Weaknesses
Table 91. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 92. GlaxoSmithKline plc Major Business
Table 93. GlaxoSmithKline plc Meningococcal Disease Vaccine Product and Services
Table 94. GlaxoSmithKline plc Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GlaxoSmithKline plc Recent Developments/Updates
Table 96. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 97. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 98. Novartis AG Major Business
Table 99. Novartis AG Meningococcal Disease Vaccine Product and Services
Table 100. Novartis AG Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Novartis AG Recent Developments/Updates
Table 102. Novartis AG Competitive Strengths & Weaknesses
Table 103. Sanofi Basic Information, Manufacturing Base and Competitors
Table 104. Sanofi Major Business
Table 105. Sanofi Meningococcal Disease Vaccine Product and Services
Table 106. Sanofi Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sanofi Recent Developments/Updates
Table 108. Sanofi Competitive Strengths & Weaknesses
Table 109. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Merck & Co., Inc. Major Business
Table 111. Merck & Co., Inc. Meningococcal Disease Vaccine Product and Services
Table 112. Merck & Co., Inc. Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck & Co., Inc. Recent Developments/Updates
Table 114. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 115. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 116. F. Hoffmann-La Roche Ltd Major Business
Table 117. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Product and Services
Table 118. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 120. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 121. Baxter Basic Information, Manufacturing Base and Competitors
Table 122. Baxter Major Business
Table 123. Baxter Meningococcal Disease Vaccine Product and Services
Table 124. Baxter Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Baxter Recent Developments/Updates
Table 126. Baxter Competitive Strengths & Weaknesses
Table 127. BIO-MED Basic Information, Manufacturing Base and Competitors
Table 128. BIO-MED Major Business
Table 129. BIO-MED Meningococcal Disease Vaccine Product and Services
Table 130. BIO-MED Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. BIO-MED Recent Developments/Updates
Table 132. BIO-MED Competitive Strengths & Weaknesses
Table 133. Bio-Manguinhos Basic Information, Manufacturing Base and Competitors
Table 134. Bio-Manguinhos Major Business
Table 135. Bio-Manguinhos Meningococcal Disease Vaccine Product and Services
Table 136. Bio-Manguinhos Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Bio-Manguinhos Recent Developments/Updates
Table 138. Walvax Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 139. Walvax Biotechnology Co., Ltd Major Business
Table 140. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Product and Services
Table 141. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Meningococcal Disease Vaccine Upstream (Raw Materials)
Table 143. Meningococcal Disease Vaccine Typical Customers
Table 144. Meningococcal Disease Vaccine Typical Distributors
Table 1. World Meningococcal Disease Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Meningococcal Disease Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Meningococcal Disease Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Meningococcal Disease Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Meningococcal Disease Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Meningococcal Disease Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Meningococcal Disease Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Meningococcal Disease Vaccine Production Market Share by Region (2018-2023)
Table 9. World Meningococcal Disease Vaccine Production Market Share by Region (2024-2029)
Table 10. World Meningococcal Disease Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Meningococcal Disease Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Meningococcal Disease Vaccine Major Market Trends
Table 13. World Meningococcal Disease Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Meningococcal Disease Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Meningococcal Disease Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Meningococcal Disease Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Meningococcal Disease Vaccine Producers in 2022
Table 18. World Meningococcal Disease Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Meningococcal Disease Vaccine Producers in 2022
Table 20. World Meningococcal Disease Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Meningococcal Disease Vaccine Company Evaluation Quadrant
Table 22. World Meningococcal Disease Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Meningococcal Disease Vaccine Production Site of Key Manufacturer
Table 24. Meningococcal Disease Vaccine Market: Company Product Type Footprint
Table 25. Meningococcal Disease Vaccine Market: Company Product Application Footprint
Table 26. Meningococcal Disease Vaccine Competitive Factors
Table 27. Meningococcal Disease Vaccine New Entrant and Capacity Expansion Plans
Table 28. Meningococcal Disease Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Meningococcal Disease Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Meningococcal Disease Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Meningococcal Disease Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Meningococcal Disease Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Meningococcal Disease Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Meningococcal Disease Vaccine Production Market Share (2018-2023)
Table 37. China Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Meningococcal Disease Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Meningococcal Disease Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Meningococcal Disease Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Meningococcal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Market Share (2018-2023)
Table 47. World Meningococcal Disease Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Meningococcal Disease Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Meningococcal Disease Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Meningococcal Disease Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Meningococcal Disease Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Meningococcal Disease Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Meningococcal Disease Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Meningococcal Disease Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Meningococcal Disease Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Meningococcal Disease Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Meningococcal Disease Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Meningococcal Disease Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Meningococcal Disease Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Meningococcal Disease Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Major Business
Table 63. AstraZeneca Meningococcal Disease Vaccine Product and Services
Table 64. AstraZeneca Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AstraZeneca Recent Developments/Updates
Table 66. AstraZeneca Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Meningococcal Disease Vaccine Product and Services
Table 70. Johnson & Johnson Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
Table 73. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 74. Mylan N.V Major Business
Table 75. Mylan N.V Meningococcal Disease Vaccine Product and Services
Table 76. Mylan N.V Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mylan N.V Recent Developments/Updates
Table 78. Mylan N.V Competitive Strengths & Weaknesses
Table 79. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Teva Pharmaceutical Industries Ltd Major Business
Table 81. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Product and Services
Table 82. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 84. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 85. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Inc Major Business
Table 87. Pfizer Inc Meningococcal Disease Vaccine Product and Services
Table 88. Pfizer Inc Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Pfizer Inc Competitive Strengths & Weaknesses
Table 91. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 92. GlaxoSmithKline plc Major Business
Table 93. GlaxoSmithKline plc Meningococcal Disease Vaccine Product and Services
Table 94. GlaxoSmithKline plc Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GlaxoSmithKline plc Recent Developments/Updates
Table 96. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 97. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 98. Novartis AG Major Business
Table 99. Novartis AG Meningococcal Disease Vaccine Product and Services
Table 100. Novartis AG Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Novartis AG Recent Developments/Updates
Table 102. Novartis AG Competitive Strengths & Weaknesses
Table 103. Sanofi Basic Information, Manufacturing Base and Competitors
Table 104. Sanofi Major Business
Table 105. Sanofi Meningococcal Disease Vaccine Product and Services
Table 106. Sanofi Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sanofi Recent Developments/Updates
Table 108. Sanofi Competitive Strengths & Weaknesses
Table 109. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Merck & Co., Inc. Major Business
Table 111. Merck & Co., Inc. Meningococcal Disease Vaccine Product and Services
Table 112. Merck & Co., Inc. Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck & Co., Inc. Recent Developments/Updates
Table 114. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 115. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 116. F. Hoffmann-La Roche Ltd Major Business
Table 117. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Product and Services
Table 118. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 120. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 121. Baxter Basic Information, Manufacturing Base and Competitors
Table 122. Baxter Major Business
Table 123. Baxter Meningococcal Disease Vaccine Product and Services
Table 124. Baxter Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Baxter Recent Developments/Updates
Table 126. Baxter Competitive Strengths & Weaknesses
Table 127. BIO-MED Basic Information, Manufacturing Base and Competitors
Table 128. BIO-MED Major Business
Table 129. BIO-MED Meningococcal Disease Vaccine Product and Services
Table 130. BIO-MED Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. BIO-MED Recent Developments/Updates
Table 132. BIO-MED Competitive Strengths & Weaknesses
Table 133. Bio-Manguinhos Basic Information, Manufacturing Base and Competitors
Table 134. Bio-Manguinhos Major Business
Table 135. Bio-Manguinhos Meningococcal Disease Vaccine Product and Services
Table 136. Bio-Manguinhos Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Bio-Manguinhos Recent Developments/Updates
Table 138. Walvax Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 139. Walvax Biotechnology Co., Ltd Major Business
Table 140. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Product and Services
Table 141. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Meningococcal Disease Vaccine Upstream (Raw Materials)
Table 143. Meningococcal Disease Vaccine Typical Customers
Table 144. Meningococcal Disease Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Meningococcal Disease Vaccine Picture
Figure 2. World Meningococcal Disease Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Meningococcal Disease Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 5. World Meningococcal Disease Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Meningococcal Disease Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Meningococcal Disease Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 10. China Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 12. Meningococcal Disease Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Meningococcal Disease Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Meningococcal Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Meningococcal Disease Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Meningococcal Disease Vaccine Markets in 2022
Figure 26. United States VS China: Meningococcal Disease Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Meningococcal Disease Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Meningococcal Disease Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Meningococcal Disease Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Meningococcal Disease Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Market Share 2022
Figure 32. World Meningococcal Disease Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Meningococcal Disease Vaccine Production Value Market Share by Type in 2022
Figure 34. Polysaccharide
Figure 35. Conjugate
Figure 36. Combination
Figure 37. World Meningococcal Disease Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Meningococcal Disease Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Meningococcal Disease Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Meningococcal Disease Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Meningococcal Disease Vaccine Production Value Market Share by Application in 2022
Figure 42. Infant
Figure 43. Child
Figure 44. Aldult
Figure 45. World Meningococcal Disease Vaccine Production Market Share by Application (2018-2029)
Figure 46. World Meningococcal Disease Vaccine Production Value Market Share by Application (2018-2029)
Figure 47. World Meningococcal Disease Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Meningococcal Disease Vaccine Industry Chain
Figure 49. Meningococcal Disease Vaccine Procurement Model
Figure 50. Meningococcal Disease Vaccine Sales Model
Figure 51. Meningococcal Disease Vaccine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Meningococcal Disease Vaccine Picture
Figure 2. World Meningococcal Disease Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Meningococcal Disease Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 5. World Meningococcal Disease Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Meningococcal Disease Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Meningococcal Disease Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 10. China Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Meningococcal Disease Vaccine Production (2018-2029) & (K Units)
Figure 12. Meningococcal Disease Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Meningococcal Disease Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Meningococcal Disease Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Meningococcal Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Meningococcal Disease Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Meningococcal Disease Vaccine Markets in 2022
Figure 26. United States VS China: Meningococcal Disease Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Meningococcal Disease Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Meningococcal Disease Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Meningococcal Disease Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Meningococcal Disease Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Meningococcal Disease Vaccine Production Market Share 2022
Figure 32. World Meningococcal Disease Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Meningococcal Disease Vaccine Production Value Market Share by Type in 2022
Figure 34. Polysaccharide
Figure 35. Conjugate
Figure 36. Combination
Figure 37. World Meningococcal Disease Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Meningococcal Disease Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Meningococcal Disease Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Meningococcal Disease Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Meningococcal Disease Vaccine Production Value Market Share by Application in 2022
Figure 42. Infant
Figure 43. Child
Figure 44. Aldult
Figure 45. World Meningococcal Disease Vaccine Production Market Share by Application (2018-2029)
Figure 46. World Meningococcal Disease Vaccine Production Value Market Share by Application (2018-2029)
Figure 47. World Meningococcal Disease Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Meningococcal Disease Vaccine Industry Chain
Figure 49. Meningococcal Disease Vaccine Procurement Model
Figure 50. Meningococcal Disease Vaccine Sales Model
Figure 51. Meningococcal Disease Vaccine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
